Methadone-related torsades de pointes in a sickle cell patient treated for chronic pain [2]

American Journal of Hematology

Volumn 78, Issue 4, 2005, Pages 316-317

  Porter, Brian O ^a   Coyne, Patrick J ^a   Smith, Wally R ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; HYDROMORPHONE; IBUPROFEN; KETOROLAC; LEVACETYLMETHADOL; METHADONE; MORPHINE;

ADULT; CANNABIS ADDICTION; CASE REPORT; CHRONIC PAIN; COCAINE DEPENDENCE; CONGESTIVE HEART FAILURE; HUMAN; HYPERTENSION; LEG PAIN; LETTER; LOW BACK PAIN; MALE; PRIORITY JOURNAL; QT PROLONGATION; SICKLE CELL ANEMIA; TORSADE DES POINTES;

ADULT; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; HUMANS; MALE; METHADONE; PAIN; TORSADES DE POINTES;

EID: 16344387918     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20304     Document Type: Letter

References (5)

1. Krantz M, Kutinsky I, Robertson A, Mehler P. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 2003;23:802-805.
2. Gil M, Sala M, Anguera I, et al. QT Prolongation and torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol 2003;92:995-997.
3. De Bels D, Staroukine M, Devriendt J. Torsades de pointes due to methadone. Ann Intern Med 2003;139:E156.
4. Kornick C, Kilborn M, Santiago-Palma J, et al. QTc interval prolongation association with intravenous methadone. Pain 2003;105:499-506.
5. Martell B, Arnsten J, Ray B, Gourevitch M. The impact of methadone induction on cardiac conduction in opiate users. Ann Intern Med 2003;139:154-155.